Challenges and opportunities in using residual newborn screening samples for translational research workshop summary / Steve Olson and Adam C. Berger, rapporteurs ; Roundtable on Translating Genomic-Based Research for Health, Board on Health Sciences Policy, Institute of Medicine of the National Academies.

Other author Olson, Steve, 1956-
Other author Berger, Adam C.
Other author Institute of Medicine (U.S.). Roundtable on Translating Genomic-Based Research for Health.
Format Electronic
Publication InfoWashington, D.C. : National Academies Press,
Descriptionxv, 67 p. : ill. ; 23 cm.
Supplemental ContentFull text available from Ebook Central - Academic Complete
Subjects

Contents Newborn screening as a public health program -- Uses of residual newborn screening samples in research -- Concerns about the use of residual newborn screening samples -- Review and consent in the use of residual newborn screening samples -- Parental and public education -- Workshop overview and wrap-up.
Abstract "Newborn screening samples are used to test more than 4 million infants each year for life-threatening diseases that are treatable if found at birth. These specimens also represent a potentially invaluable resource for public health and biomedical research. The IOM held a workshop to examine issues surrounding the use of residual specimens for translational research."
Bibliography noteIncludes bibliographical references.
Access restrictionAvailable only to authorized users.
Other formsAlso available online.
Technical detailsMode of access: World Wide Web
Genre/formElectronic books.
LCCN 2010284667
ISBN0309159547
ISBN9780309159548

Availability

Library Location Call Number Status Item Actions
Electronic Resources Access Content Online ✔ Available